- Home
- TLSA vs KNDI Comparison
TLSA vs KNDI Comparison
Compare TLSA & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- KNDI
- Stock Information
- Founded
- TLSA 2013
- KNDI 2002
- Country
- TLSA United Kingdom
- KNDI China
- Employees
- TLSA N/A
- KNDI N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- KNDI Auto Manufacturing
- Sector
- TLSA Health Care
- KNDI Consumer Discretionary
- Exchange
- TLSA Nasdaq
- KNDI Nasdaq
- Market Cap
- TLSA 175.3M
- KNDI 96.3M
- IPO Year
- TLSA 2000
- KNDI N/A
- Fundamental
- Price
- TLSA $1.56
- KNDI $1.12
- Analyst Decision
- TLSA
- KNDI
- Analyst Count
- TLSA 0
- KNDI 0
- Target Price
- TLSA N/A
- KNDI N/A
- AVG Volume (30 Days)
- TLSA 265.3K
- KNDI 93.5K
- Earning Date
- TLSA 07-11-2025
- KNDI 08-15-2025
- Dividend Yield
- TLSA N/A
- KNDI N/A
- EPS Growth
- TLSA N/A
- KNDI N/A
- EPS
- TLSA N/A
- KNDI N/A
- Revenue
- TLSA N/A
- KNDI $127,569,613.00
- Revenue This Year
- TLSA N/A
- KNDI N/A
- Revenue Next Year
- TLSA N/A
- KNDI N/A
- P/E Ratio
- TLSA N/A
- KNDI N/A
- Revenue Growth
- TLSA N/A
- KNDI 3.21
- 52 Week Low
- TLSA $0.63
- KNDI $0.89
- 52 Week High
- TLSA $1.91
- KNDI $2.24
- Technical
- Relative Strength Index (RSI)
- TLSA 52.92
- KNDI 48.39
- Support Level
- TLSA $1.53
- KNDI $1.06
- Resistance Level
- TLSA $1.81
- KNDI $1.16
- Average True Range (ATR)
- TLSA 0.11
- KNDI 0.07
- MACD
- TLSA -0.00
- KNDI 0.01
- Stochastic Oscillator
- TLSA 48.26
- KNDI 43.07
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.